T0	Disease 74 81	cancers
#1	AnnotatorNotes T0	DOID:162
T1	Disease 146 151	tumor
#2	AnnotatorNotes T1	DOID:162
T10	Disease 486 494	lymphoma
#3	AnnotatorNotes T10	DOID:0060058
T11	Drug 576 586	disulfiram
T12	Drug 588 590	DS
T14	Chemical 599 601	Cu
T15	Chemical 633 656	reactive oxygen species
T17	Disease 859 867	lymphoma
T18	Disease 922 942	mantle cell lymphoma
#11	AnnotatorNotes T18	DOID:0050746
T2	Disease 197 208	lung cancer
#13	AnnotatorNotes T2	DOID:1324
T20	Drug 1072 1082	bortezomib
T21	Drug 1156 1166	bortezomib
T22	Drug 1336 1346	bortezomib
T23	Disease 1361 1381	mantle cell lymphoma
T24	Drug-Class 1470 1482	chemotherapy
T25	Disease 1509 1517	lymphoma
T3	Disease 217 237	pancreatic carcinoma
#20	AnnotatorNotes T3	DOID:4905
T4	Disease 251 264	breast cancer
#21	AnnotatorNotes T4	DOID:1612
T6	Disease 307 322	prostate cancer
#23	AnnotatorNotes T6	DOID:10283
T7	Disease 331 348	ovarian carcinoma
#24	AnnotatorNotes T7	DOID:4001
T8	Disease 365 380	cervical cancer
#25	AnnotatorNotes T8	DOID:4362
T9	Disease 405 431	hematopoietic malignancies
#26	AnnotatorNotes T9	DOID:2531
T26	Gene-Protein 83 87	Nrf2
#4	AnnotatorNotes T26	HGNC:7782
T27	Disease 278 298	head and neck cancer
#5	AnnotatorNotes T27	DOID:11934
T28	Gene-Protein 467 471	Nrf2
T29	Gene-Protein 667 671	Nrf2
T30	Gene-Protein 818 822	Nrf2
#6	AnnotatorNotes T11	CHEMBL964
T5	Gene-Protein 952 956	Nrf2
#7	AnnotatorNotes T12	CHEMBL964
T31	Drug 596 598	DS
T32	Gene-Protein 1121 1125	Nrf2
T33	Gene-Protein 1297 1301	Nrf2
T34	Gene-Protein 1431 1435	Nrf2
T13	Drug 976 986	bortezomib
#8	AnnotatorNotes T13		CHEMBL325041
T19	CellLine 1009 1013	Jeko
T35	CellLine 1018 1022	SP53
T36	CellLine 1050 1054	Mino
T37	CellLine 1059 1064	Rec-1
T38	Drug-Class 113 125	chemotherapy
T39	Biomarker 1412 1446	elevated Keap1 and Nrf2 expression
T40	Gene-Protein 1421 1426	Keap1
#10	AnnotatorNotes T40	HGNC:23177
T41	Biomarker 467 482	Nrf2 expression
T42	Drug 804 833	inhibition of Nrf2 expression
#12	AnnotatorNotes T42	not found
R1	Association Arg1:T41 Arg2:T10	
T43	Collection 197 380	lung cancer ( 27 ), pancreatic carcinoma ( 23 , 28 ), breast cancer ( 29 , 30 ), head and neck cancer ( 31 ), prostate cancer ( 32 ), ovarian carcinoma ( 33 , 34 ) and cervical cancer
T44	Biomarker 83 87	Nrf2
R2	Mediated-Non-Response Arg1:T38 Arg2:T43	
R3	Mediator Arg1:T38 Arg2:T44	
R4	Response Arg1:T42 Arg2:T17	
T45	Biomarker 1121 1152	Nrf2 expression was upregulated
T46	Biomarker 1288 1312	elevated Nrf2 expression
R5	Mediated-Non-Response Arg1:T22 Arg2:T23	
R7	Mediator Arg1:T22 Arg2:T46	
T47	CellLine 545 559	Raji cell line
#9	AnnotatorNotes T44	C495635
